Paper36293239
Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer.
Jayaprakash S and 7 others. Int J Mol Sci, 2022. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer. Papers, record 36293239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36293239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ubiquitin-Protein Ligases | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Nedd4 Ubiquitin Protein Ligases | |
| Endosomal Sorting Complexes Required for Transport | |
| Ubiquitination | |
| Carcinogenesis | |
| Ubiquitins |
Source PubMed
References276
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33004065 | The role of ubiquitination and deubiquitination in cancer metabolism. | Mol Cancer | 2020 | https://conductscience.org/library/papers/33004065 | PubMed |
| 2 | 30417127 | Estradiol promotes rapid degradation of HER3 in ER-positive breast cancer cell line MCF-7. | Biochem Biophys Rep | 2018 | https://conductscience.org/library/papers/30417127 | PubMed |
| 3 | 27097161 | Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway. | PLoS One | 2016 | https://conductscience.org/library/papers/27097161 | PubMed |
| 4 | 28574057 | New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles. | Cancer Gene Ther | 2017 | https://conductscience.org/library/papers/28574057 | PubMed |
| 5 | 27882436 | A novel 4,6-disubstituted-1,2,4-triazolo-1,3,4-thiadiazole derivative inhibits tumor cell invasion and potentiates the apoptotic effect of TNFα by abrogating NF-κB activation cascade. | Apoptosis | 2017 | https://conductscience.org/library/papers/27882436 | PubMed |
| 6 | 28771691 | Targeting HECT-type E3 ligases - insights from catalysis, regulation and inhibitors. | FEBS Lett | 2017 | https://conductscience.org/library/papers/28771691 | PubMed |
| 7 | 27119228 | NEDL2 regulates enteric nervous system and kidney development in its Nedd8 ligase activity-dependent manner. | Oncotarget | 2016 | https://conductscience.org/library/papers/27119228 | PubMed |
| 8 | 30967264 | Decreased expression of NEDD4L contributes to NSCLC progression and metastasis. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/30967264 | PubMed |
| 9 | 24456330 | Pathobiological properties of the ubiquitin ligase Nedd4L in melanoma. | Int J Exp Pathol | 2014 | https://conductscience.org/library/papers/24456330 | PubMed |
| 10 | 26297204 | Lung cancer: Biology and treatment options. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/26297204 | PubMed |
| 11 | 31761807 | What Is Cancer? | Perspect Biol Med | 2019 | https://conductscience.org/library/papers/31761807 | PubMed |
| 12 | 18812566 | Nedd4 controls animal growth by regulating IGF-1 signaling. | Sci Signal | 2008 | https://conductscience.org/library/papers/18812566 | PubMed |
| 13 | 31605013 | PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1. | Oncogene | 2020 | https://conductscience.org/library/papers/31605013 | PubMed |
| 14 | 33184448 | Suppression of the USP10/CCND1 axis induces glioblastoma cell apoptosis. | Acta Pharmacol Sin | 2021 | https://conductscience.org/library/papers/33184448 | PubMed |
| 15 | 33962630 | NEDD4 regulates ubiquitination and stability of the cell adhesion molecule IGPR-1 via lysosomal pathway. | J Biomed Sci | 2021 | https://conductscience.org/library/papers/33962630 | PubMed |
| 16 | 32408623 | Therapeutic Emergence of Rhein as a Potential Anticancer Drug: A Review of Its Molecular Targets and Anticancer Properties. | Molecules | 2020 | https://conductscience.org/library/papers/32408623 | PubMed |
| 17 | 18604872 | Tumour-promoting activity of altered WWP1 expression in breast cancer and its utility as a prognostic indicator. | J Pathol | 2008 | https://conductscience.org/library/papers/18604872 | PubMed |
| 18 | 15688069 | Proteolysis: from the lysosome to ubiquitin and the proteasome. | Nat Rev Mol Cell Biol | 2005 | https://conductscience.org/library/papers/15688069 | PubMed |
| 19 | 27796923 | Recent development of targeted approaches for the treatment of breast cancer. | Breast Cancer | 2017 | https://conductscience.org/library/papers/27796923 | PubMed |
| 20 | 29246645 | Therapeutic potential of gambogic acid, a caged xanthone, to target cancer. | Cancer Lett | 2018 | https://conductscience.org/library/papers/29246645 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42526820 | Optimization of the recombinant overexpression and purification of human Nedd4-1 in Escherichia coli. | Protein Expr Purif | 2027 | https://conductscience.org/library/papers/42526820 | PubMed |
| 42120529 | Network-based analysis reveals potential microRNA regulation of oncogenic pathways in SOX10-depleted uveal melanoma. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/42120529 | PubMed |
| 41561975 | Integrated network toxicology, machine learning algorithms and TMT proteomics reveal the mechanism of 18β glycyrrhetinic acid against gastric cancer. | Front Genet | 2025 | https://conductscience.org/library/papers/41561975 | PubMed |
| 41413572 | RNF152-mediated, ubiquitin-dependent degradation of HSP27 activates the PI3K/AKT pathway, driving synovial inflammatory cascades in TMJOA. | Arthritis Res Ther | 2025 | https://conductscience.org/library/papers/41413572 | PubMed |
| 40526226 | Comprehensive analysis of the role of NEDD4 in pan-cancer and experimental verification of its role in KIRC progression. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40526226 | PubMed |
| 40319310 | DNA methylation in primary myelofibrosis is partly associated with driver mutations and distinct from other myeloid malignancies. | Clin Epigenetics | 2025 | https://conductscience.org/library/papers/40319310 | PubMed |
| 40002221 | A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40002221 | PubMed |
| 39851497 | Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities. | Cells | 2025 | https://conductscience.org/library/papers/39851497 | PubMed |
| 39707500 | Impact of c-JUN deficiency on thalamus development in mice and human neural models. | Cell Biosci | 2024 | https://conductscience.org/library/papers/39707500 | PubMed |
| 39678832 | Prognostic value of ubiquitination-related differentially expressed genes in esophageal squamous cell carcinoma: a comprehensive analysis and future directions. | J Thorac Dis | 2024 | https://conductscience.org/library/papers/39678832 | PubMed |
| 39015146 | The E3 ubiquitin ligase Nedd4L preserves skeletal muscle stem cell quiescence by inhibiting their activation. | iScience | 2024 | https://conductscience.org/library/papers/39015146 | PubMed |
| 38859858 | Unraveling role of ubiquitination in drug resistance of gynecological cancer. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/38859858 | PubMed |
| 38785984 | NEDD4 and NEDD4L: Ubiquitin Ligases Closely Related to Digestive Diseases. | Biomolecules | 2024 | https://conductscience.org/library/papers/38785984 | PubMed |
| 37497216 | E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies. | Front Immunol | 2023 | https://conductscience.org/library/papers/37497216 | PubMed |
| 37359559 | Elucidating the role of ubiquitination and deubiquitination in osteoarthritis progression. | Front Immunol | 2023 | https://conductscience.org/library/papers/37359559 | PubMed |
| 37215134 | The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37215134 | PubMed |
| 36902094 | Overexpression of a Novel Noxo1 Mutant Increases Ros Production and Noxo1 Relocalisation. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902094 | PubMed |
Genes130
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36293239
GET https://conductscience.org/api/papers/v1/36293239/references?page=2